These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 35589093)

  • 1. Smoking As an Outcome Moderator In the Treatment of Alcohol Use Disorders.
    van Amsterdam J; van den Brink W
    Alcohol Alcohol; 2022 Nov; 57(6):664-673. PubMed ID: 35589093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of alcohol use on smoking cessation: A systematic review.
    van Amsterdam J; van den Brink W
    Alcohol; 2023 Jun; 109():13-22. PubMed ID: 36690220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naltrexone improves quit rates, attenuates smoking urge, and reduces alcohol use in heavy drinking smokers attempting to quit smoking.
    Fridberg DJ; Cao D; Grant JE; King AC
    Alcohol Clin Exp Res; 2014 Oct; 38(10):2622-9. PubMed ID: 25335648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alcohol use disorder severity moderates clinical response to varenicline.
    Donato S; Green R; Ray LA
    Alcohol Clin Exp Res; 2021 Sep; 45(9):1877-1887. PubMed ID: 34486130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tobacco use during a clinical trial of mecamylamine for alcohol dependence: Medication effects on smoking and associations with reductions in drinking.
    Roberts W; Ralevski E; Verplaetse TL; McKee SA; Petrakis IL
    J Subst Abuse Treat; 2018 Nov; 94():91-96. PubMed ID: 30243424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Level of Alcohol Consumption and Successful Smoking Cessation.
    Lynch KL; Twesten JE; Stern A; Augustson EM
    Nicotine Tob Res; 2019 Jul; 21(8):1058-1064. PubMed ID: 29986105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders.
    Apollonio D; Philipps R; Bero L
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD010274. PubMed ID: 27878808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Double-Blind Randomized Placebo-Controlled Trial of Oral Naltrexone for Heavy-Drinking Smokers Seeking Smoking Cessation Treatment.
    Kahler CW; Cioe PA; Tzilos GK; Spillane NS; Leggio L; Ramsey SE; Brown RA; O'Malley SS
    Alcohol Clin Exp Res; 2017 Jun; 41(6):1201-1211. PubMed ID: 28401564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between relapse and drinking behaviors in patients with alcohol use disorders: A 6-month prospective study.
    Kurihara K; Shinzato H; Takaesu Y; Kondo T
    Neuropsychopharmacol Rep; 2023 Dec; 43(4):633-640. PubMed ID: 38069609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Randomized Trial Evaluating Whether Topiramate Aids Smoking Cessation and Prevents Alcohol Relapse in Recovering Alcohol-Dependent Men.
    Anthenelli RM; Heffner JL; Wong E; Tibbs J; Russell K; Isgro M; Dinh E; Wehrle C; Worley MJ; Doran N
    Alcohol Clin Exp Res; 2017 Jan; 41(1):197-206. PubMed ID: 28029173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Varenicline on Alcohol Consumption in Subjects With Alcohol Use Disorders: Systematic Review and Meta-Analyses.
    Gandhi KD; Mansukhani MP; Karpyak VM; Schneekloth TD; Wang Z; Kolla BP
    J Clin Psychiatry; 2020 Feb; 81(2):. PubMed ID: 32097546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Meta-Regression of Trial Features Predicting the Effects of Alcohol Use Disorder Pharmacotherapies on Drinking Outcomes in Randomized Clinical Trials: A Secondary Data Analysis.
    Grodin EN; Donato S; Du H; Green R; Bujarski S; Ray LA
    Alcohol Alcohol; 2022 Sep; 57(5):589-594. PubMed ID: 35229869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Concurrent inpatient smoking cessation and alcohol abstinence programs for alcoholics and their outcomes].
    Yokoyama A; Mizukami T; Nakayama H; Takimura T; Sakuma H; Yoshimura A; Yoneda J; Maesato H; Kimura M; Matsushita S; Higuchi S
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2014 Dec; 49(6):381-90. PubMed ID: 25831952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a technology-based, integrated smoking cessation and alcohol intervention for smoking cessation in adolescents: Results of a cluster-randomised controlled trial.
    Haug S; Paz Castro R; Kowatsch T; Filler A; Schaub MP
    J Subst Abuse Treat; 2017 Nov; 82():55-66. PubMed ID: 29021116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of a clinical decision support system on prompting an intervention for risky alcohol use in a primary care smoking cessation program: a cluster randomized trial.
    Minian N; Baliunas D; Noormohamed A; Zawertailo L; Giesbrecht N; Hendershot CS; Le Foll B; Rehm J; Samokhvalov AV; Selby PL
    Implement Sci; 2019 Aug; 14(1):85. PubMed ID: 31443663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-dependent reduction of hazardous alcohol use in a placebo-controlled trial of naltrexone for smoking cessation.
    O'Malley SS; Krishnan-Sarin S; McKee SA; Leeman RF; Cooney NL; Meandzija B; Wu R; Makuch RW
    Int J Neuropsychopharmacol; 2009 Jun; 12(5):589-97. PubMed ID: 18796184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in Nicotine Metabolite Ratio Among Daily Smokers Receiving Treatment for Alcohol Use Disorder.
    Dermody SS; Hendershot CS; Andrade AK; Novalen M; Tyndale RF
    Nicotine Tob Res; 2020 Feb; 22(2):256-263. PubMed ID: 30561731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment retention and reductions in blood alcohol concentration (BAC) during the first 90 days of a telehealth program for alcohol use disorder.
    Hallgren KA; Galloway GP; Witkiewitz K; Linde P; Nix B; Mendelson JE
    Am J Drug Alcohol Abuse; 2023 Mar; 49(2):249-259. PubMed ID: 36881813
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial.
    Aubin HJ; Lebargy F; Berlin I; Bidaut-Mazel C; Chemali-Hudry J; Lagrue G
    Addiction; 2004 Sep; 99(9):1206-18. PubMed ID: 15317642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent alcohol and tobacco treatment: Effect on daily process measures of alcohol relapse risk.
    Cooney NL; Litt MD; Sevarino KA; Levy L; Kranitz LS; Sackler H; Cooney JL
    J Consult Clin Psychol; 2015 Apr; 83(2):346-58. PubMed ID: 25622198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.